ZA922976B - 4-Aryl-3-heteroarylureidoquinoline derivatives - Google Patents
4-Aryl-3-heteroarylureidoquinoline derivativesInfo
- Publication number
- ZA922976B ZA922976B ZA922976A ZA922976A ZA922976B ZA 922976 B ZA922976 B ZA 922976B ZA 922976 A ZA922976 A ZA 922976A ZA 922976 A ZA922976 A ZA 922976A ZA 922976 B ZA922976 B ZA 922976B
- Authority
- ZA
- South Africa
- Prior art keywords
- heteroarylureidoquinoline
- aryl
- derivatives
- heteroarylureidoquinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69232391A | 1991-04-26 | 1991-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA922976B true ZA922976B (en) | 1993-10-25 |
Family
ID=24780107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA922976A ZA922976B (en) | 1991-04-26 | 1992-03-24 | 4-Aryl-3-heteroarylureidoquinoline derivatives |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0590094A1 (xx) |
JP (1) | JPH0776215B2 (xx) |
CN (1) | CN1066068A (xx) |
AU (1) | AU1879792A (xx) |
BR (1) | BR9205939A (xx) |
CA (1) | CA2108014A1 (xx) |
CZ (1) | CZ395592A3 (xx) |
DE (1) | DE9290049U1 (xx) |
FI (1) | FI934710A (xx) |
HU (1) | HUT65748A (xx) |
IE (1) | IE921330A1 (xx) |
IL (1) | IL101627A0 (xx) |
MX (1) | MX9201916A (xx) |
NO (1) | NO933837L (xx) |
NZ (1) | NZ242493A (xx) |
PT (1) | PT100426A (xx) |
TW (1) | TW197436B (xx) |
WO (1) | WO1992019614A1 (xx) |
YU (1) | YU44592A (xx) |
ZA (1) | ZA922976B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2125325T3 (es) * | 1992-01-23 | 1999-03-01 | Pfizer | Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos. |
US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
CA2222687A1 (en) * | 1995-05-31 | 1996-12-05 | Masami Muraoka | Novel naphthyridine derivatives |
KR20000057268A (ko) * | 1996-11-26 | 2000-09-15 | 다께우찌 마사야쓰 | 나프티리딘 유도체 |
US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
CA2321237A1 (en) | 1998-02-25 | 1999-09-02 | Masami Muraoka | Pyridone derivatives and process for producing the same |
TW200529845A (en) | 2003-12-12 | 2005-09-16 | Wyeth Corp | Quinolines useful in treating cardiovascular disease |
CN103601677B (zh) * | 2013-11-19 | 2015-11-18 | 清华大学 | 制备2-烷硫基喹啉衍生物的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
WO1991004027A1 (en) * | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
TW205037B (xx) * | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd |
-
1992
- 1992-03-16 CA CA002108014A patent/CA2108014A1/en not_active Abandoned
- 1992-03-16 WO PCT/US1992/001801 patent/WO1992019614A1/en not_active Application Discontinuation
- 1992-03-16 HU HU9303025A patent/HUT65748A/hu active IP Right Revival
- 1992-03-16 AU AU18797/92A patent/AU1879792A/en not_active Abandoned
- 1992-03-16 BR BR9205939A patent/BR9205939A/pt not_active Application Discontinuation
- 1992-03-16 CZ CS923955A patent/CZ395592A3/cs unknown
- 1992-03-16 DE DE9290049U patent/DE9290049U1/de not_active Expired - Lifetime
- 1992-03-16 EP EP92923349A patent/EP0590094A1/en not_active Withdrawn
- 1992-03-16 JP JP4510186A patent/JPH0776215B2/ja not_active Expired - Lifetime
- 1992-03-17 TW TW081102005A patent/TW197436B/zh active
- 1992-03-24 ZA ZA922976A patent/ZA922976B/xx unknown
- 1992-04-16 IL IL101627A patent/IL101627A0/xx unknown
- 1992-04-24 IE IE133092A patent/IE921330A1/en not_active Application Discontinuation
- 1992-04-24 YU YU44592A patent/YU44592A/sh unknown
- 1992-04-24 NZ NZ242493A patent/NZ242493A/en unknown
- 1992-04-24 MX MX9201916A patent/MX9201916A/es not_active IP Right Cessation
- 1992-04-24 PT PT100426A patent/PT100426A/pt not_active Application Discontinuation
- 1992-04-25 CN CN92103010A patent/CN1066068A/zh active Pending
-
1993
- 1993-10-25 FI FI934710A patent/FI934710A/fi unknown
- 1993-10-25 NO NO933837A patent/NO933837L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CA2108014A1 (en) | 1992-10-27 |
HU9303025D0 (en) | 1994-01-28 |
FI934710A0 (fi) | 1993-10-25 |
NZ242493A (en) | 1994-08-26 |
PT100426A (pt) | 1993-08-31 |
JPH06501025A (ja) | 1994-01-27 |
IL101627A0 (en) | 1992-12-30 |
JPH0776215B2 (ja) | 1995-08-16 |
CZ395592A3 (en) | 1994-02-16 |
EP0590094A1 (en) | 1994-04-06 |
NO933837L (no) | 1993-10-25 |
DE9290049U1 (de) | 1994-01-05 |
AU1879792A (en) | 1992-12-21 |
YU44592A (sh) | 1994-12-28 |
IE921330A1 (en) | 1992-11-04 |
TW197436B (xx) | 1993-01-01 |
CN1066068A (zh) | 1992-11-11 |
WO1992019614A1 (en) | 1992-11-12 |
FI934710A (fi) | 1993-10-25 |
HUT65748A (en) | 1994-07-28 |
BR9205939A (pt) | 1994-09-27 |
MX9201916A (es) | 1992-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3023621T3 (en) | 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives | |
EP0440950A3 (en) | Halogenallyl-azolyl derivatives | |
HU912356D0 (en) | Rapacmycine derivatives | |
EP0470466A3 (en) | Halogenalkyl-azolyl derivatives | |
HU9203994D0 (en) | Imidazo-pyridine derivatives | |
EP0436333A3 (en) | Azaoxindole derivatives | |
HRP930485A2 (en) | Hiv-inhibiting benzenacetamide derivatives | |
HU9202768D0 (en) | Cyano-phenyl-pyrrole derivatives | |
EP0485984A3 (en) | Diarylmethoxypiperidine derivatives | |
HU9202388D0 (en) | Aryl-alkyl-amine derivatives | |
ZA92278B (en) | 3-quinuclidine derivatives | |
ZA922976B (en) | 4-Aryl-3-heteroarylureidoquinoline derivatives | |
EP0520435A3 (en) | Dc-89 derivatives | |
GB9007569D0 (en) | Carbo-nucleoside derivatives | |
EP0440949A3 (en) | Halogenallyl-azolyl derivatives | |
HU9200011D0 (en) | Trifluoro-methyl-1-carba(1-dethia)-cepheme derivatives | |
GB2262739B (en) | Benzofuranylimidazole derivatives | |
ZA92786B (en) | Pyrimidinyl-and triazinylsalicyl-and-picolinylaldehyde derivatives | |
AP9100308A0 (en) | Carboxymethylcyclopropane derivatives | |
EP0453883A3 (en) | 2-amino-4-trichloropyridine derivatives | |
HU9200105D0 (en) | Bipiridyl derivatives | |
GB2249094B (en) | Hetero-imidazodiazepine derivatives | |
GB9213972D0 (en) | 3-cycloalkyl-prop-2-enamide derivatives | |
GB9106070D0 (en) | Benzodioxanylimidazole derivatives | |
ZA924959B (en) | Hydroisoquinoline derivatives |